NuVasive, Inc. (NUVA)
A medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders.
Recs
Rapid revenue growth in minimally invasive spine surgery
Recs
pt47, z1
Recs
Recs
better tech and mkting force thans comps
Recs
As u can see in the stock trends, it is already higher then S&P 500 and it's going to keep outperforming S&P 500. Nuvasive has a product that everybody needs. Look at there sales and stock price in the past couples of yeear, they outperformed wall street prediction.
Recs
innovative product.
Recs
Recs
Makes complete systems for minimally invasive spine fusion surgery. The older we get, the more likely we are to need such surgery. I think the stock is the next Intuitive Surgical (ISRG).
Recs
Recs
This stock is awesome. I wouldn't have even known about it, but I sat next to an employee on an aircraft and he amazed me with the technology this co. is coming up with for what used to be tremendously invasive surg. Back surg. done via laparoscopy essentially....I look for this to hit the 100 mark in 5 yrs.
Recs
Nice solid chart pattern (technically) with fabulous growth (fundamentally).
Recs
Good spine company building business, taking market share in a growing business. Good buyout target from one of the big boys like JNJ or MDT.
Recs
Triple AAA stock to have in your portfolio.
Stock price keeps growing & growing like ever-ready bunny!
Recs
This company is gowing at a 50% rate and should turn profitable in the 3rd quarter. It could be another ISRG only dealing with the spine.
Recs
Company revenues up 96% for last 3 years. THis could be the next intutive surgical.
Recs
NuVasive, Inc. designs, develops, and markets products for the surgical treatment of disorders of the spine, focusing mainly on spinal fusion. It features a minimally invasive surgical platform called Maximum Access Surgery (MAS), which uses a software-driven nerve
avoidance system called NeuroVision, and MaXcess, a retraction system that allows for smaller incisions compared to open surgical techniques.
2003 2004 2005 2006 2007
Revenues ($mill) 22.7 38.4 61.8 98.1 145
and 0 debt.
Recs
Vol Incr IBD+
3 mo EPS + Surp
Owned by Fid Contra, RS, Kopp, Sands & NA
Recs
I have played this story before and money each time. Now I want to hold longer as this company is really coming together in its model. They have a fantastic medical techology platform for back surgery. Could be a take at some point in the next couple of years.
Recs
Strong growth potential for medical devices and procedures for back surgery that are less invasive. Many big name backers
Recs
great stock to trade between 18-21, low float

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 20